See also this year's filing and all EDGAR filings for this company.
PDF Report 0000875622_2019_BIOSPECIFICS_TECHNOLOGIES_CORP.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000875622')"} |
Graph
Absolute values for 0000875622, BIOSPECIFICS TECHNOLOGIES CORP
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 98,233,962 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 444,478 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 1,413,602 |
| 4 | LiabilitiesCurrent | 2,503,522 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 8,805,989 |
| 9 | ResearchAndDevelopmentExpense | 756,776 |
| 10 | remainder_Expenses | 4,744,008 |
| 11 | remainder_Revenues | 32,961,443 |
| 12 | remainder_NetIncome | 1,398,599 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 100,092,042 |
| 1 | Liabilities | 2,503,522 |
| 2 | Expenses | 14,306,773 |
| 3 | Revenues | 32,961,443 |
| 4 | StockholdersEquity | 97,588,520 |
| 5 | NetIncome | 20,053,269 |
| 6 | ComprehensiveNetIncome | 20,053,269 |
| 7 | BaseVar | 75,631,190 |
| 8 | EconomicCapitalRatio | 3.66 |
Edgar->Model Mapping
Feature Distribution
Change over Time
